Cargando…

Corrigendum to Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467368/ https://www.ncbi.nlm.nih.gov/pubmed/37624676 http://dx.doi.org/10.1177/10760296231196695

Ejemplares similares

Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation
por: Zhang, Xu, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
por: Ma, Fang, et al.
Publicado: (2022)

Comparison of Efficacy and Safety of Anticoagulant Monotherapy and Combined Therapy of Anticoagulant and Antiplatelets in Patients With Stable Coronary Artery Disease and Atrial Fibrillation: A Meta-Analysis
por: Tentu, Niharika, et al.
Publicado: (2022)

Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis
por: Fu, Wenbin, et al.
Publicado: (2014)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
por: Jang, Soo Min, et al.
Publicado: (2020)

Corrigendum: Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study
Publicado: (2021)

Corrigendum: Interventional Therapy for Bilateral Acute Renal Artery Embolism Caused by Paroxysmal Atrial Fibrillation
Publicado: (2016)

Corrigendum to: Rotor mechanism and its mapping in atrial fibrillation
Publicado: (2023)

Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Deng, Kaisheng, et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies
por: Cao, Bo, et al.
Publicado: (2021)

Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]
por: Zhu, Jing, et al.
Publicado: (2023)

CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
por: Suwa, Michihiro, et al.
Publicado: (2023)

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
por: Vallakati, Ajay, et al.
Publicado: (2016)

Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Corrigendum to: Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Publicado: (2018)

Editorial to the “safety and efficacy of direct oral anticoagulants compared to vitamin K antagonist post percutaneous coronary artery interventions in patients with atrial fibrillation: A systematic revie and meta‐analysis”
por: Okumura, Yasuo, et al.
Publicado: (2020)

Anticoagulation in Patients with Atrial Fibrillation and Coronary Artery Disease
por: Alkindi, Fahad Abdullah, et al.
Publicado: (2020)

The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Salah, Qais M, et al.
Publicado: (2023)

Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta‐analysis
por: Agasthi, Pradyumna, et al.
Publicado: (2020)

Corrigendum to “Efficacy and Safety of Butorphanol Use in Patient-Controlled Analgesia: A Meta-Analysis”
por: Zhu, Zhihua, et al.
Publicado: (2021)

Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum]
Publicado: (2013)

Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
por: Basu Roy, Prithvi, et al.
Publicado: (2023)

Corrigendum to “Factors Associated with the Incidence and Severity of New-Onset Atrial Fibrillation in Adult Critically Ill Patients”
por: Duarte, Péricles A. D., et al.
Publicado: (2019)

Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
por: Yamato, Hiroshi, et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review
por: Acanfora, Domenico, et al.
Publicado: (2019)

Efficacy of Chloral Hydrate Oral Solution for Sedation in Pediatrics: a Systematic Review and Meta-Analysis [Corrigendum]
Publicado: (2022)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation
por: Lega, Jean-Christophe, et al.
Publicado: (2014)

Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation
por: Franchina, Antonio Gabriele, et al.
Publicado: (2023)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3q3iufisg11e76b9dd2lae9628